2022•Journal of NeuroscienceOpen access

The Ups and Downs of Endocannabinoid Signaling in Chronic Pain-Induced Depression

N. T. Wilkinson

Open full text 2 citations

Abstract

Individuals with chronic pain often experience depression, resulting in greater disability and a worse prognosis than either condition alone ([Goesling et al., 2013][1]). The prevalence of depression among individuals experiencing neuropathic pain, one type of chronic pain caused by injury of the

Open-access reader

About this research paper

What this paper is about

Individuals with chronic pain often experience depression, resulting in greater disability and a worse prognosis than either condition alone ([Goesling et al., 2013][1]). The prevalence of depression among individuals experiencing neuropathic pain, one type of chronic pain caused by injury of the

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Individuals with chronic pain often experience depression, resulting in greater disability and a worse prognosis than either condition alone ([Goesling et al., 2013][1]). The prevalence of depression among individuals experiencing neuropathic pain, one type of chronic pain caused by injury of the

Key concepts: Depression (economics), Chronic pain, Endocannabinoid system, Neuropathic pain, Medicine, Psychiatry, Psychology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The Ups and Downs of Endocannabinoid Signaling in Chronic Pain-Induced Depression — Research Paper | ScholarLens